Context Therapeutics, Inc. (CNTX)
0.4676
-0.03
(-6.50%)
USD |
NASDAQ |
Aug 24, 16:00
0.4676
0.00 (0.00%)
After-Hours: 19:19
Context Therapeutics Total Liabilities (Quarterly) : 7.962M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 7.962M |
| March 31, 2026 | 6.657M |
| December 31, 2025 | 8.02M |
| September 30, 2025 | 6.057M |
| June 30, 2025 | 4.608M |
| March 31, 2025 | 1.983M |
| December 31, 2024 | 2.860M |
| September 30, 2024 | 2.472M |
| June 30, 2024 | 1.604M |
| March 31, 2024 | 2.608M |
| December 31, 2023 | 4.192M |
| Date | Value |
|---|---|
| September 30, 2023 | 4.604M |
| June 30, 2023 | 3.757M |
| March 31, 2023 | 3.233M |
| December 31, 2022 | 3.208M |
| September 30, 2022 | 4.012M |
| June 30, 2022 | 3.048M |
| March 31, 2022 | 1.638M |
| December 31, 2021 | 3.033M |
| September 30, 2021 | 4.409M |
| June 30, 2021 | 3.960M |
| March 31, 2021 | 3.367M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Merck & Co., Inc. | 87.82B |
| ANI Pharmaceuticals, Inc. | 896.90M |
| Corcept Therapeutics, Inc. | 182.93M |
| Veru, Inc. | 8.651M |
| Johnson & Johnson | 116.09B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 46.13M |
| Shareholders Equity (Quarterly) | 38.17M |
| Debt to Equity Ratio | 0.0064 |
| Current Ratio | 5.786 |
| Net Debt Paydown Yield | -0.02% |